Cell and Gene Therapy, Industry
July 20, 2022
Via: Biopharma DiveRoche is putting more money into gene therapies for eye diseases, announcing a deal to work with University of Pittsburgh spinout Avista Therapeutics to develop better delivery tools for the complex treatments. Through the deal, Avista will develop new capsids, […]
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
September 14, 2023
August 30, 2023